Opko Health (OPK) Q1 2026 Earnings
Opko Health reported Q1 2026 revenue of $124.2M (-17.2% YoY), missed analyst consensus of $130.5M by $6.3M. Diluted EPS came in at $-0.07 (+30.0% YoY).
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Opko Health's Q1 2026 earnings report.
Opko Health (OPK) reported Q1 2026 earnings on April 28, 2026 after market close.
Opko Health reported revenue of $124.2M and diluted EPS of $-0.07 for Q1 2026.
Revenue missed the consensus estimate of $130.5M by $6.3M. EPS beat the consensus estimate of $-0.07 by $0.00.
Compared to the same quarter a year prior, revenue declined 17.2% from $150.0M a year earlier and diluted EPS grew 30.0% from $-0.10.
You can read the 8-K earnings release (0001193125-26-186939) and the 10-Q periodic report (0001193125-26-187007) directly on SEC EDGAR. The filing index links above go to sec.gov.